433 related articles for article (PubMed ID: 26197393)
1. Suppression of Propionibacterium acnes Infection and the Associated Inflammatory Response by the Antimicrobial Peptide P5 in Mice.
Ryu S; Han HM; Song PI; Armstrong CA; Park Y
PLoS One; 2015; 10(7):e0132619. PubMed ID: 26197393
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory and anti-inflammatory effects of the Helicobacter pylori-derived antimicrobial peptide HPA3NT3 against Propionibacterium acnes in the skin.
Ryu S; Park Y; Kim B; Cho SM; Lee J; Lee HH; Gurley C; Song K; Johnson A; Armstrong CA; Song PI
Br J Dermatol; 2014 Dec; 171(6):1358-67. PubMed ID: 25313444
[TBL] [Abstract][Full Text] [Related]
3. The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris.
Han R; Blencke HM; Cheng H; Li C
Peptides; 2018 Jan; 99():36-43. PubMed ID: 29108811
[TBL] [Abstract][Full Text] [Related]
4. Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.
Popovic S; Urbán E; Lukic M; Conlon JM
Peptides; 2012 Apr; 34(2):275-82. PubMed ID: 22374306
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory properties of a new undecyl-rhamnoside (APRC11) against P. acnes.
Isard O; Lévêque M; Knol AC; Ariès MF; Khammari A; Nguyen JM; Castex-Rizzi N; Dréno B
Arch Dermatol Res; 2011 Dec; 303(10):707-13. PubMed ID: 21461892
[TBL] [Abstract][Full Text] [Related]
6. CBT-SL5, a bacteriocin from Enterococcus faecalis, suppresses the expression of interleukin-8 induced by Propionibacterium acnes in cultured human keratinocytes.
Lee YJ; Choi HJ; Kang TW; Kim HO; Chung MJ; Park YM
J Microbiol Biotechnol; 2008 Jul; 18(7):1308-16. PubMed ID: 18667861
[TBL] [Abstract][Full Text] [Related]
7. Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes.
Lee SE; Kim JM; Jeong SK; Jeon JE; Yoon HJ; Jeong MK; Lee SH
Arch Dermatol Res; 2010 Dec; 302(10):745-56. PubMed ID: 20697725
[TBL] [Abstract][Full Text] [Related]
8.
Hwang DH; Lee DY; Koh PO; Yang HR; Kang C; Kim E
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138302
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic effect of tanshinone IIA on Propionibacterium acnes-induced inflammation in vitro.
Li Y; Zhou Y
Dermatol Ther; 2018 Nov; 31(6):e12716. PubMed ID: 30246913
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of the antimicrobial peptide BLP-7 against Propionibacterium acnes and its anti-inflammatory effect on acne vulgaris.
Wu Y; Qiang Y; Cao K; Zhang W; Zhang G
Toxicon; 2020 Sep; 184():109-115. PubMed ID: 32540219
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial efficacy of granulysin-derived synthetic peptides in acne vulgaris.
Lim HS; Chun SM; Soung MG; Kim J; Kim SJ
Int J Dermatol; 2015 Jul; 54(7):853-62. PubMed ID: 25601314
[TBL] [Abstract][Full Text] [Related]
12. Effects of bee venom against Propionibacterium acnes-induced inflammation in human keratinocytes and monocytes.
Kim JY; Lee WR; Kim KH; An HJ; Chang YC; Han SM; Park YY; Pak SC; Park KK
Int J Mol Med; 2015 Jun; 35(6):1651-6. PubMed ID: 25872535
[TBL] [Abstract][Full Text] [Related]
13. SIG1459: A novel phytyl-cysteine derived TLR2 modulator with in vitro and clinical anti-acne activity.
Fernández JR; Webb C; Rouzard K; Healy J; Tamura M; Voronkov M; Huber KL; Stock JB; Stock M; Gordon JS; Pérez E
Exp Dermatol; 2018 Sep; 27(9):993-999. PubMed ID: 29797368
[TBL] [Abstract][Full Text] [Related]
14. A Rationally Designed Multifunctional Antibiotic for the Treatment of Drug-Resistant Acne.
Ghosh S; Sinha M; Bhattacharyya A; Sadhasivam S; Megha J; Reddy S; Saini S; Singh H; Kumar D; Kaur SP; Mishra M; Usharani D; Ghosh S; Sengupta S
J Invest Dermatol; 2018 Jun; 138(6):1400-1408. PubMed ID: 29409921
[TBL] [Abstract][Full Text] [Related]
15. SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin.
Fernandéz JR; Rouzard K; Voronkov M; Feng X; Stock JB; Stock M; Gordon JS; Shroot B; Christensen MS; Pérez E
J Cosmet Dermatol; 2012 Dec; 11(4):272-8. PubMed ID: 23174050
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris.
Marta Guarna M; Coulson R; Rubinchik E
FEMS Microbiol Lett; 2006 Apr; 257(1):1-6. PubMed ID: 16553825
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids enhance Toll-like receptor 2 expression in human keratinocytes stimulated with Propionibacterium acnes or proinflammatory cytokines.
Shibata M; Katsuyama M; Onodera T; Ehama R; Hosoi J; Tagami H
J Invest Dermatol; 2009 Feb; 129(2):375-82. PubMed ID: 18704103
[TBL] [Abstract][Full Text] [Related]
18. Propionibacterium acnes-Derived Extracellular Vesicles Promote Acne-Like Phenotypes in Human Epidermis.
Choi EJ; Lee HG; Bae IH; Kim W; Park J; Lee TR; Cho EG
J Invest Dermatol; 2018 Jun; 138(6):1371-1379. PubMed ID: 29409885
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcal LTA-Induced miR-143 Inhibits Propionibacterium acnes-Mediated Inflammatory Response in Skin.
Xia X; Li Z; Liu K; Wu Y; Jiang D; Lai Y
J Invest Dermatol; 2016 Mar; 136(3):621-630. PubMed ID: 26739093
[TBL] [Abstract][Full Text] [Related]
20. Suppression of
Lee EH; Shin JH; Kim SS; Joo JH; Choi E; Seo SR
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31319552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
